Following the success of their 2015 meeting Global Engage is pleased to announce the 2nd Annual Biologics Congress 2016 which will be held on February 1-2 in Berlin, Germany. It will co-located with our Biosimilars Congress which is being introduced this year after much demand.The conferences are part of our successful Drug Discovery series which includes events on synthetic biology, precision medicine, digital pathology, digital PCR and the human microbiome. The Biologics market is evolving with the development of new products and therapies and is expected to hit $200 billion in the next few years. With growing commercial potential, good economic returns and lower attrition rates when compared to small molecule drugs and entry barriers on the manufacturing side reducing all the time, more and more companies are entering the expanding field.Attracting industry & academic experts working in all areas of protein and antibody research this two day interactive meeting will provide you the opportunity to take home cutting edge strategies, case study examples, developments and methods to allow you to further your research, keep abreast of your competitors and the latest technology/solution advancements in the area.